Diagnostics
-
The image by Coolcaesar is licensed under CC BY-SA 4.0
Danaher’s Cepheid business to lay off 67 people in California
The job cuts at Danaher’s molecular diagnostics subsidiary will take place by the end of the year and affect mostly scientists and engineers, according to a state filing.
By Susan Kelly • Nov. 11, 2026 -
Virtuoso robot wins FDA nod for bladder tumor removal
Virtuoso Surgical’s robotic system can remove lesions in one piece in a minimally invasive procedure designed to improve cancer diagnosis and staging.
By Susan Kelly • Nov. 10, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Labcorp completes $375M Millennium Health takeover
The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.
By Nick Paul Taylor • Nov. 9, 2026 -
Natera promotes Solomon Moshkevich to CEO
The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for the role.
By Susan Kelly • Nov. 6, 2026 -
Siemens Healthineers to rebrand and separate its IVD business
The company is rebranding the unit as Olyrian Diagnostics and plans to set it up as a standalone business by mid-2028.
By Nick Paul Taylor • Nov. 6, 2026 -
Bracco invests $230M to build US plant for injectable contrast media
The Sanford, North Carolina, facility will become the company’s first manufacturing site for injectable contrast media in the U.S.
By Nick Paul Taylor • Nov. 3, 2026 -
Labcorp, Quest urge RESULTS Act passage as lab payment cuts loom
The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross the finish line in Congress’ lame-duck session.
By Susan Kelly • Oct. 30, 2026 -
Abbott launches MRD test with improved cancer detection tech
Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.
By Susan Kelly • Oct. 27, 2026 -
Labcorp inks Millennium Health buyout to add drug testing services
The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.
By Nick Paul Taylor • Oct. 26, 2026 -
Qiagen agrees to private equity takeover
EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.
By Susan Kelly • Oct. 23, 2026 -
Labcorp to buy Myriad’s prenatal health testing unit for $210M
Buying the Myriad assets will expand Labcorp’s portfolio of specialty tests for women’s health.
By Nick Paul Taylor • Oct. 22, 2026 -
5 doctors weigh in on the promise, limitations of Grail’s multicancer test
As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.
By Susan Kelly • Oct. 19, 2026 -
Labcorp to buy BioReference assets for up to $872M
Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.
By Susan Kelly • Oct. 15, 2026 -
Siemens Healthineers to stop selling general ultrasound systems
In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries
By Elise Reuter • Oct. 14, 2026 -
Agilent to buy Proscia for $240M
The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.
By Nick Paul Taylor • Oct. 14, 2026 -
Philips updates instructions for ultrasound system linked to 4 deaths
A software issue can delay use of the Lumify diagnostic ultrasound system in environments without access to Wi-Fi or cellular signal.
By Nick Paul Taylor • Oct. 12, 2026 -
BD strikes supply chain pact with Trump administration
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
By Susan Kelly • Oct. 6, 2026 -
GE HealthCare to acquire Sofie Biosciences for $945M
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
By Susan Kelly • Oct. 5, 2026 -
ARPA-H awards more than $100M to biosensor development projects
Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.
By Nick Paul Taylor • Oct. 5, 2026 -
Sponsored by Veeva MedTech
Thermo Fisher Scientific accelerates market access by prioritizing the right KOLs
Thermo Fisher turned fragmented KOL data into real-time market demand. Read how.
Oct. 5, 2026 -
FDA to prioritize guidance on AI, surgical robots next year
The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.
By Nick Paul Taylor • Oct. 2, 2026 -
Abbott launches Freenome’s colorectal cancer screening test
Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.
By Susan Kelly • Sept. 30, 2026 -
Lab test providers want Medicare payment reform. Will Congress pass it?
Facing maximum Medicare payment cuts, test providers Quest Diagnostics and Labcorp are urging lawmakers to revamp the rate-setting process, but getting a bill through Congress this year will be a challenge.
By Susan Kelly • Sept. 25, 2026 -
Grail multicancer detection test wins FDA advisers’ backing
Members of the molecular and clinical genetics panel said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings.
By Susan Kelly • Sept. 24, 2026 -
CMS sets preliminary cuts to Medicare lab reimbursement rates
The American Clinical Laboratory Association warned the steep annual payment cuts threaten patient access to critical lab testing services.
By Susan Kelly • Sept. 22, 2026